Posts Slider

CardioOne Secures $8M, Expands Cardiology Care Delivery Enablement Platform In 5 Markets –
What You Should Know: CardioOne, a cardiology care delivery enablement platform for independent cardiology practices, $8M in initial funding and three new partnerships with independent...

Correcting Provider Biases About Transgender and Gender Non-Conforming Patients Can Protect Their Health and Safety
Conscious or subconscious biases that some doctors, nurses, administrators and health insurers hold about transgender and transgender non-conforming (TGNC) people are likely contributing to their...

Health gains from rare disease, specialty and expedited review drugs – Healthcare Economist
James Chambers has put together a series of papers looking at health gains (and cost effectiveness) using the Tufts Cost Effectiveness Analysis Registry. In these...

Motif Neurotech Conducts First-In-Human Brain Stimulation for Treatment-resistant Depression –
What You Should Know: Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health, announced new research published to the preprint server medrxiv that demonstrates...

How Genome Sequencing Can Broaden the Scope of Newborn Screening
Soon after birth, a baby receives its first diagnostic test—a small heel prick yielding several blood drops analyzed for dozens of inherited conditions. Newborn screening...
Posts Grid
CardioOne Secures $8M, Expands Cardiology Care Delivery Enablement Platform In 5 Markets –
What You Should Know: CardioOne, a cardiology care delivery enablement platform for independent cardiology practices, $8M in initial funding and three new partnerships with independent...
Correcting Provider Biases About Transgender and Gender Non-Conforming Patients Can Protect Their Health and Safety
Conscious or subconscious biases that some doctors, nurses, administrators and health insurers hold about transgender and transgender non-conforming (TGNC) people are likely contributing to their...
Health gains from rare disease, specialty and expedited review drugs – Healthcare Economist
James Chambers has put together a series of papers looking at health gains (and cost effectiveness) using the Tufts Cost Effectiveness Analysis Registry. In these...
Motif Neurotech Conducts First-In-Human Brain Stimulation for Treatment-resistant Depression –
What You Should Know: Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health, announced new research published to the preprint server medrxiv that demonstrates...
How Genome Sequencing Can Broaden the Scope of Newborn Screening
Soon after birth, a baby receives its first diagnostic test—a small heel prick yielding several blood drops analyzed for dozens of inherited conditions. Newborn screening...
Senior Living Braces for a New Era of Search
The way in which older adults and their families search for senior living is changing. As baby boomers and their Generation X children are aging...